Both in Biotechnology
IRulya Therapeutics vs Alector
Over the past year IRLA returned +22.8% and ALEC returned +17.8%; their daily moves had a correlation of 0.48.
IRLA +22.8% ALEC +17.8%Growth of $1, one year, split-adjusted
| Metric | IRLA | ALEC |
|---|---|---|
| Price | $39.78 | $2.45 |
| Market cap | $431.3M | $364.7M |
| Today | +3.78% | −6.84% |
| 1 month | +32.6% | +30.3% |
| 6 months | — | +6.5% |
| Year to date | — | +57.1% |
| 1 year | — | +80.1% |
| Revenue growth (YoY) | — | +4895.9% |
| Gross margin | — | 100.0% |
| Net margin | — | 76.5% |
| P/E (TTM) | — | 8.9× |
| Price / sales | — | 2.1× |
| Net cash | — | $138.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 87.1% |
| Short % of float | 14.2% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).